| Head and Neck Cancers, Version 1.2015 | 2015/07/01 | English | 154 |
| Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology | 2018/09/01 | English | 153 |
| NCCN Guidelines Insights: Kidney Cancer, Version 2.2020 | 2019/11/01 | | 151 |
| Neoadjuvant Chemotherapy First, Followed by Chemoradiation and Then Surgery, in the Management of Locally Advanced Rectal Cancer | 2014/04/01 | English | 150 |
| The Epidemic of HPV-Associated Oropharyngeal Cancer Is Here: Is It Time to Change Our Treatment Paradigms? | 2011/06/01 | | 150 |
| Genetic/Familial High-Risk Assessment: Breast and Ovarian | 2010/05/01 | | 149 |
| NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018 | 2018/11/01 | English | 145 |
| NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021 | 2021/04/01 | | 145 |
| Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology | 2020/10/01 | | 144 |
| Adolescent and Young Adult Oncology | 2012/09/01 | English | 143 |
| Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology | 2019/12/01 | | 142 |
| Rectal Cancer | 2009/09/01 | English | 142 |
| Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology | 2016/04/01 | English | 142 |
| Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology | 2016/08/01 | English | 141 |
| Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology | 2017/02/01 | English | 141 |
| NCCN Guidelines Insights: Kidney Cancer, Version 1.2021 | 2020/09/01 | | 140 |
| Kidney Cancer | 2009/06/01 | | 140 |
| Sentinel Lymph Node Mapping for Endometrial Cancer: A Modern Approach to Surgical Staging | 2014/02/01 | English | 140 |
| NCCN Guidelines Insights: Bladder Cancer, Version 5.2018 | 2018/09/01 | English | 137 |
| Esophageal and Esophagogastric Junction Cancers | 2011/08/01 | | 137 |
| Breast Cancer Version 3.2014 | 2014/04/01 | English | 137 |
| Rectal Cancer, Version 2.2015 | 2015/06/01 | English | 136 |
| Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology | 2021/12/01 | | 133 |
| Fatigue is the Most Important Symptom for Advanced Cancer Patients Who Have Had Chemotherapy | 2008/05/01 | English | 133 |
| NCCN Task Force Report: Bone Health in Cancer Care | 2013/08/01 | English | 133 |
| NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017 | 2017/11/01 | English | 131 |
| Neuroendocrine Tumors | 2012/06/01 | English | 131 |
| New NCCN Guidelines: Recognition and Management of Immunotherapy-Related Toxicity | 2018/05/01 | English | 129 |
| Gastric Cancer: A Primer on the Epidemiology and Biology of the Disease and an Overview of the Medical Management of Advanced Disease | 2010/04/01 | | 129 |
| Palliative Care | 2009/04/01 | | 128 |